4.4.2. Exclusion Criteria
AIDS, glomerular kidney disease, tumor, chronic fungal infections, HIV infection, non-melanoma skin cancer, tuberculosis, liver cirrhosis, muscle-invasive bladder tumors, leprosy, adenocarcinoma, chronic parasitic diseases, bullous skin diseases
RHEUMATOID ARTHRITIS, BLADDER TUMORS, TUMOR, INTERSTITIAL LUNG DISEASES, BULLOUS SKIN DISEASE, MULTIPLE SCLEROSIS, PULMONARY FIBROSIS, LEPROSY, SQUAMOUS CELL CARCINOMA, CHRONIC KIDNEY FAILURE, OTHER MALIGNANT NEOPLASM, HIV INFECTION, AIDS, TUBERCULOSIS, LIVER CIRRHOSIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, OPTIC NEURITIS, CONGESTIVE HEART FAILURE, ADENOCARCINOMA, CHRONIC VIRAL HEPATITIS, UROTHELIAL CARCINOMA, SYSTEMIC LUPUS ERYTHEMATOSUS, SCLERODERMA
Patients meeting any of the following criteria were excluded from the current study:Diagnosis of muscle-invasive bladder tumors.Metastatic bladder tumors.Histological types other than urothelial carcinoma, including adenocarcinoma and squamous cell carcinoma.Patients with cardiac function classified as higher than class III since it indicates the need of cardiac procedures or treatments.Presence of comorbidities, such as demyelinating diseases of the central nervous system (e.g., multiple sclerosis, optic neuritis), congestive heart failure class II or higher, chronic obstructive pulmonary disease, interstitial lung diseases (including pulmonary fibrosis), tuberculosis (any form), chronic kidney failure stage II or higher, liver cirrhosis of any cause, chronic viral hepatitis, HIV infection (with or without AIDS), leprosy, systemic lupus erythematosus, rheumatoid arthritis, scleroderma, any glomerular kidney disease, bullous skin diseases, chronic fungal infections, chronic parasitic diseases, or being a transplant recipient on immunosuppressants.Current or prior diagnosis of any other malignant neoplasm (except for non-melanoma skin cancer) unrelated to the inclusion tumor.Having access to any antineoplastic immunotherapy approved to treat their respective tumor.